ScoreWhy is Bristol Myers Squibb Co. ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 6.47% and Operating profit at 23.31%
2
The company has declared positive results in Mar'2025 after 4 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at USD 15,901 MM
- ROCE(HY) Highest at 29.31%
- DIVIDEND PER SHARE(HY) Highest at USD 3.15
3
With ROCE of 19.69%, it has a fair valuation with a 3.08 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -11.00%, its profits have risen by 1.8% ; the PEG ratio of the company is 10.5
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -11.00% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Bristol Myers Squibb Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bristol Myers Squibb Co. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Bristol Myers Squibb Co.
-11.0%
0.76
29.12%
S&P 500
13.22%
0.65
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.47%
EBIT Growth (5y)
23.31%
EBIT to Interest (avg)
5.76
Debt to EBITDA (avg)
1.96
Net Debt to Equity (avg)
2.19
Sales to Capital Employed (avg)
0.68
Tax Ratio
10.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
84.07%
ROCE (avg)
13.51%
ROE (avg)
33.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
7.62
EV to EBIT
15.62
EV to EBITDA
9.01
EV to Capital Employed
3.08
EV to Sales
3.58
PEG Ratio
10.51
Dividend Yield
76.91%
ROCE (Latest)
19.69%
ROE (Latest)
49.65%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 15,901 MM
ROCE(HY)
Highest at 29.31%
DIVIDEND PER SHARE(HY)
Highest at USD 3.15
INTEREST COVERAGE RATIO(Q)
Highest at 1,061.03
RAW MATERIAL COST(Y)
Fallen by -18.34% (YoY
OPERATING PROFIT(Q)
Highest at USD 5,146 MM
PRE-TAX PROFIT(Q)
Highest at USD 4,411 MM
NET PROFIT(Q)
Highest at USD 3,263.58 MM
-1What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 6.28 times
Here's what is working for Bristol Myers Squibb Co.
Operating Cash Flow
Highest at USD 15,901 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Interest Coverage Ratio
Highest at 1,061.03
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Dividend per share
Highest at USD 3.15 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Operating Profit
Highest at USD 5,146 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 4,411 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD 4,411 MM has Grown at 61.4%
over average net sales of the previous four periods of USD 2,733 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 3,263.58 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD 3,263.58 MM has Grown at 51.51%
over average net sales of the previous four periods of USD 2,154.07 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by -18.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Bristol Myers Squibb Co.
Inventory Turnover Ratio
Lowest at 6.28 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
